Alowa, Filma R.
HRN: 21-28-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/30/2022
05/07/2022
IV
600mg
Q8H
Pleural Effusion, L, CAP-MR
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes